Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy EAM Ruigrok, N van Vliet, SU Dalm, E de Blois, DC van Gent, J Haeck, ... European journal of nuclear medicine and molecular imaging 48, 1339-1350, 2021 | 61 | 2021 |
Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approach L Alic, JC Haeck, K Bol, S Klein, ST van Tiel, PA Wielepolski, M de Jong, ... PLoS One 6 (8), e22835, 2011 | 45 | 2011 |
Encapsulation of allogeneic mesenchymal stem cells in alginate extends local presence and therapeutic function MJC Leijs, E Villafuertes, J Haeck, WJLM Koevoet, B Fernandez-Gutierrez, ... European cells & materials 33, 43-58, 2017 | 40 | 2017 |
Theranostic design of angiopep-2 conjugated hyaluronic acid nanoparticles (Thera-ANG-cHANPs) for dual targeting and boosted imaging of glioma cells A Costagliola di Polidoro, G Zambito, J Haeck, L Mezzanotte, M Lamfers, ... Cancers 13 (3), 503, 2021 | 38 | 2021 |
MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study S Khatab, MJ Leijs, G van Buul, J Haeck, N Kops, M Nieboer, PK Bos, ... Cell Biology and Toxicology 36, 553-570, 2020 | 38 | 2020 |
Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response D Feijtel, GN Doeswijk, NS Verkaik, JC Haeck, D Chicco, C Angotti, ... Theranostics 11 (2), 491, 2021 | 33 | 2021 |
Preclinical efficacy and safety evaluation of hematopoietic stem cell gene therapy in a mouse model of MNGIE R Yadak, R Cabrera-Pérez, J Torres-Torronteras, M Bugiani, JC Haeck, ... Molecular therapy Methods & clinical development 8, 152-165, 2018 | 24 | 2018 |
SSTR-mediated imaging in breast cancer: is there a role for radiolabeled somatostatin receptor antagonists? SU Dalm, J Haeck, GN Doeswijk, E de Blois, M de Jong, ... Journal of Nuclear Medicine 58 (10), 1609-1614, 2017 | 24 | 2017 |
Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies SM Bison, JC Haeck, K Bol, SJ Koelewijn, HC Groen, M Melis, ... EJNMMI research 5, 1-11, 2015 | 22 | 2015 |
Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? K Bol, JC Haeck, HC Groen, WJ Niessen, MR Bernsen, M de Jong, ... PloS one 8 (10), e77076, 2013 | 21 | 2013 |
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer IL Bakker, ST van Tiel, J Haeck, GN Doeswijk, E de Blois, M Segbers, ... Molecular Imaging and Biology 20, 973-983, 2018 | 17 | 2018 |
Multi-modal image registration: matching MRI with histology L Alic, JC Haeck, S Klein, K Bol, ST Van Tiel, PA Wielopolski, M Bijster, ... Medical Imaging 2010: Biomedical Applications in Molecular, Structural, and …, 2010 | 17 | 2010 |
Fluorinated PLGA-PEG-mannose nanoparticles for tumor-associated macrophage detection by optical imaging and MRI G Zambito, S Deng, J Haeck, N Gaspar, U Himmelreich, R Censi, C Löwik, ... Frontiers in medicine 8, 712367, 2021 | 15 | 2021 |
In Vivo Evaluation of Indium-111–Labeled 800CW as a Necrosis-Avid Contrast Agent MCM Stroet, E de Blois, DC Stuurman, CMA de Ridder, J Haeck, ... Molecular Imaging and Biology 22, 1333-1341, 2020 | 12 | 2020 |
Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI JC Haeck, K Bol, CMA de Ridder, L Brunel, JA Fehrentz, J Martinez, ... EJNMMI research 6, 1-9, 2016 | 12 | 2016 |
Optimized time‐resolved imaging of contrast kinetics (TRICKS) in dynamic contrast‐enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models J Haeck, K Bol, S Bison, S van Tiel, S Koelewijn, M de Jong, J Veenland, ... Contrast media & molecular imaging 10 (6), 413-420, 2015 | 12 | 2015 |
Computed tomography and magnetic resonance imaging MR Bernsen, A Ruggiero, M van Straten, G Kotek, JC Haeck, ... Molecular Imaging in Oncology, 3-63, 2013 | 12* | 2013 |
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo F Briest, EJ Koziolek, J Albrecht, F Schmidt, MR Bernsen, J Haeck, ... Neoplasia 23 (1), 80-98, 2021 | 10 | 2021 |
Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label LE Duinhouwer, BJM Van Rossum, ST van Tiel, RM van der Werf, ... PLoS One 10 (9), e0138572, 2015 | 9 | 2015 |
Towards complete tumor resection: Novel dual-modality probes for improved image-guided surgery of grpr-expressing prostate cancer M Handula, M Verhoeven, KT Chen, J Haeck, M de Jong, SU Dalm, ... Pharmaceutics 14 (1), 195, 2022 | 8 | 2022 |